Dr. Warren Swee, MD

Dr. Swee practices at Cli Vascular Specialists in West Palm Beach, Florida.

Dr. Swee's NPI, 1639387624, was assigned on May 21, 2007. Dr. Swee graduated from George Washington University School of Medicine and Health Sciences in 2001. Dr. Swee holds Florida license ME108929.

Dr. Swee's primary practice is Cli Vascular Specialists, at 4700 N Congress Ave, West Palm Beach, FL 33407 in Palm Beach County. The practice phone is (561) 594-1840.

Dr. Swee's primary practice is Cli Vascular Specialists in West Palm Beach, Florida. Dr. Swee is also affiliated with HCA Florida JFK Hospital. The medical group on file is CLI Vascular Specialists. Dmand AI also links Dr. Swee to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Swee practices, 4 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Swee's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Swee is board certified in interventional radiology and diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Swee's licenses on file in 6 states: Florida, Illinois, Texas, Nebraska, Virginia and Maryland.

CMS data shows 2,458 Medicare services from Dr. Swee across 19 procedure codes in 2024, for 505 Medicare patients. Medicare paid $686,465 for them.

CMS counts 505 Medicare patients who saw Dr. Swee in 2024. The largest group is 75 to 84, with 212 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Swee's median patient age at 72, with 57% women.

In 2024, Dr. Swee wrote 224 Medicare Part D claims for 95 patients. 67% of them were for generic drugs. CMS names the drug for 199 of them, across 4 drugs with 11 or more claims each, at $69,359 in total drug cost. In 2023, CMS named 252 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Swee for performance year 2024, reported as part of a group. Dr. Swee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Swee as offering telehealth. CMS counts 106 procedures of leg revascularization (restoring blood flow) by Dr. Swee, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 7 papers to Dr. Swee, published from 2013 to 2024. The most frequent topics are Balloon Occlusion, Embolization, Therapeutic and Esophageal and Gastric Varices. Dr. Swee has published most often in J Vasc Interv Radiol. Dr. Swee's most frequent co-authors are Ulku C. Turba, MD, Stephen H. Caldwell and Nadine Abi-Jaoudeh, MD.

Dmand AI links Dr. Swee to 4 clinical trials. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 360 general payments to Dr. Swee from 34 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 63% of the total. AngioDynamics, Inc. paid the most, $225,808.

Dmand AI lists 1 award for Dr. Swee.

Dr. Swee graduated from George Washington University School of Medicine and Health Sciences in 2001. Dr. Swee is a member of SIR.

Dr. Swee is in network with 13 carriers, including United Healthcare, Cigna and Elevance. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.